RxSight (NASDAQ:RXST) Given “Underperform” Rating at Bank of America
RxSight (NASDAQ:RXST – Get Free Report)‘s stock had its “underperform” rating restated by equities research analysts at Bank of America in a research report issued to clients and investors on Thursday, Marketbeat.com reports. They currently have a $22.00 target price on the stock, down from their previous target price of $36.00. Bank of America‘s target […]
RxSight (NASDAQ:RXST – Get Free Report)‘s stock had its “underperform” rating restated by equities research analysts at Bank of America in a research report issued to clients and investors on Thursday, Marketbeat.com reports. They currently have a $22.00 target price on the stock, down from their previous target price of $36.00. Bank of America‘s target […]
